XBiotech Inc. — Director's Dealing 2018

Dec 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2018-12-19

Reporting Person: SIMARD JOHN (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-19	Common Stock	M	50000	$2.50	Acquired	6327060	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-19	Stock Option	$2.50	M	50000	Disposed	2019-01-01	Common Stock (50000)	Direct